Back
Equity Residential 10K Form
Sell
27
EQR
Equity Residential
Last Price:
56.02
Seasonality Move:
3.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-02-18 | 10K | EQR/Equity Residential Annual |
2020-10-30 | 10Q | EQR/Equity Residential Quarterly |
2020-08-03 | 10Q | EQR/Equity Residential Quarterly |
2020-05-07 | 10Q | EQR/Equity Residential Quarterly |
2020-02-20 | 10K | EQR/Equity Residential Annual |
2019-10-30 | 10Q | EQR/Equity Residential Quarterly |
Receive EQR News And Ratings
See the #1 stock for the next 7 days that we like better than EQR
EQR Financial Statistics
Sales & Book Value
Annual Sales: | $2.74B |
---|---|
Cash Flow: | $250.41M |
Price / Cash Flow: | 17.84 |
Annual Sales: | $29.43 |
Price / Book: | 1.9 |
Profitability
EPS (TTM): | 2.06000 |
---|---|
Net Income (TTM): | $776.91M |
Gross Margin: | $1.75B |
Return on Equity: | 7.1% |
Return on Assets: | 3.77% |
Equity Residential Earnings Forecast
Key Equity Residential Financial Ratios
- The Gross Profit Margin over the past 16 years for EQR is 64.08%.
- The Selling, General & Administrative Expenses for EQR have been equal to 2.15% of Gross Profit Margin.
- The Interest Expense is 36.42% of Operating Income.
- The Net Earning history of EQR is 28.40% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 16 years.
Equity Residential Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | REIT - Residential |
Sector: | Real Estate |
Current Symbol: | EQR |
CUSIP: | 29476L |
Website: | equityapartments.com |
Debt
Debt-to-Equity Ratio: | 0.66 |
---|---|
Current Ratio: | 0.26 |
Quick Ratio: | 0.1 |
Price-to-Earnings
Trailing P/E Ratio: | 27.31 |
---|---|
Forward P/E Ratio: | 31.47 |
EQR Technical Analysis vs Fundamental Analysis
Sell
27
Equity Residential (EQR)
is a Sell
Is Equity Residential a Buy or a Sell?
-
Equity Residential stock is rated a Sell
The current Equity Residential [EQR] share price is $55.99. The Score for EQR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.